Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
Titel:
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
Auteur:
Aix, Santiago Ponce Ciuleanu, Tudor Eliade Navarro, Alejandro Cousin, Sophie Bonanno, Laura Smit, Egbert F Chiappori, Alberto Olmedo, Maria Eugenia Horvath, Ildiko Grohé, Christian Farago, Anna F López-Vilariño, José Antonio Cullell-Young, Martin Nieto, Antonio Vasco, Noelia Gómez, Javier Kahatt, Carmen Zeaiter, Ali Carcereny, Enric Roubec, Jaromir Syrigos, Konstantinos Lo, Gregory Barneto, Isidoro Pope, Anthony Sánchez, Amparo Kattan, Joseph Zarogoulidis, Konstantinos Waller, Cornelius F Bischoff, Helge Juan-Vidal, Oscar Reinmuth, Niels Dómine, Manuel Paz-Ares, Luis